World Journal of Oncology, ISSN 1920-4531 print, 1920-454X online, Open Access
Article copyright, the authors; Journal compilation copyright, World J Oncol and Elmer Press Inc
Journal website https://www.wjon.org

Original Article

Volume 14, Number 6, December 2023, pages 457-463

The Role of Crohn Disease on Breast Cancer Incidence: A Clinical Analysis

Figures

Figure 1.
Figure 1. Analysis of the incidence of breast cancer in patients with (dark blue) and without (light blue) a history of CD, matched by age range and CCI score. From the total of 53,000,000 patients in the database, 70,027 patients were matched into either the group of patients with (dark blue) and without (light blue) CD. The incidence of breast cancer was then subsequently measured in each group. The gender breakdown of these cases was then evaluated. CD: Crohn disease; CCI: Charlson Comorbidity Index.
Figure 2.
Figure 2. Incidence of breast cancer in patients with (dark blue) or without (light blue) a prior history of CD. Significance was measured using the Student’s t-test. *P < 0.05. CD: Crohn disease.
Figure 3.
Figure 3. Prevalence of breast cancer by age group and presence (dark blue) or absence (light blue) of CD. *Number of patients ≤ 11. The exact number of patients could not be provided due to HIPAA constraints. CD: Crohn disease; HIPAA: Health Insurance Portability and Accountability Act (HIPAA).
Figure 4.
Figure 4. Regions of breast cancer development in the USA amongst individuals with (dark blue) and without (light blue) CD. CD: Crohn disease.
Figure 5.
Figure 5. Average paid per visit for a breast cancer patient with (dark blue) or without (light blue) a prior history of CD. CD: Crohn disease.